Question marks over South Africa's ARV tender

South Africa's new ARV tender represents big business for pharmaceutical companies. (Image: Juda Ngwenya/PlusNews)

"The tender specifications were simply released - many of the recommendations made were either ignored or shot down. There has been a severe lack of transparency or participation," said Jonathan Berger, a senior researcher at the AIDS Law Project (ALP), which submitted recommendations for the 2008 tender in September 2007.

Read the full article.